Trials / Completed
CompletedNCT02062125
Calcinosis in a Single-Center Scleroderma Population
A Prospective, Observational Study of Calcinosis in a Single-Center Population With Scleroderma-Spectrum Disorders
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (actual)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a 10 year study of scleroderma patients with calcinosis 1) to better understand how common and if there are any risk factors for having calcinosis 2\) to identify common complications associated with scleroderma-related calcinosis. .
Detailed description
This is a prospective study of scleroderma- spectrum patients focused on soft tissue calcinosis in order 1) to better understand the risk factors (including clinical/laboratory characteristics, and serology) of calcinosis in the scleroderma-spectrum disorders (limited or diffuse systemic sclerosis with or without overlap of inflammatory arthritis and/or myositis). 2\) view common complications associated with calcinosis. Better understanding of scleroderma calcinosis would lead to other studies that eventually will define better treatment options for this incurable and often disabling complication.
Conditions
Timeline
- Start date
- 2012-10-31
- Primary completion
- 2024-03-15
- Completion
- 2024-03-15
- First posted
- 2014-02-13
- Last updated
- 2024-03-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02062125. Inclusion in this directory is not an endorsement.